AnPac Bio-Medical Science Co., Ltd. Operating Income 2011-2026 | ANPC

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income AnPac Bio-Medical Science Co., Ltd.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-105 M	-112 M	-94.6 M	-89.1 M	-43.6 M	-	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
-43.6 M	-112 M	-88.8 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-65.1 M	-	10.36 %	$ 9.8 M	USA
Genfit SA GNFT	31.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-452 M	$ 215.54	-1.16 %	$ 5 B	Danmark
Aptinyx APTX	-62.6 M	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	-71.1 M	$ 3.88	-1.27 %	$ 415 M	USA
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	140 M	$ 19.23	-	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
Corbus Pharmaceuticals Holdings CRBP	-85.3 M	$ 8.18	-2.97 %	$ 109 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	-9.89 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	447 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-244 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	-121 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	-139 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	-17.3 M	$ 0.71	17.15 %	$ 8.13 M	Israel
Avenue Therapeutics ATXI	-11.3 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-241 M	$ 1.32	-5.71 %	$ 337 M	Britain
CytomX Therapeutics CTMX	-22.4 M	$ 4.24	-4.83 %	$ 585 M	USA
Cyclacel Pharmaceuticals CYCC	-12 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	-130 M	-	-	$ 3.74 B	USA
Genmab A/S GMAB	2.64 B	$ 25.81	0.51 %	$ 16.6 B	Danmark
Aytu BioScience AYTU	-7.83 M	$ 2.65	0.76 %	$ 16.6 M	USA
Dynavax Technologies Corporation DVAX	-4.12 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	37.1 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	-189 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	-844 K	$ 22.97	-3.53 %	$ 618 M	USA
Exelixis EXEL	872 M	$ 41.57	0.39 %	$ 11.3 B	USA
Bellerophon Therapeutics BLPH	-22.4 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Fortress Biotech FBIO	-110 M	$ 2.92	-2.01 %	$ 60.7 M	USA
Arbutus Biopharma Corporation ABUS	-38.2 M	$ 4.31	-2.49 %	$ 826 M	Canada
Homology Medicines FIXX	16.9 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA